Contact Us    855-RIA-PLAN (855-742-7526)

MRSN: Mersana Therapeutics Inc Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 408.46
Enterprise Value ($M) 222.00
Book Value ($M) 155.55
Book Value / Share 2.16
Price / Book 2.63
NCAV ($M) 137.32
NCAV / Share 1.91
Price / NCAV 2.97

Profitability (mra)
Return on Invested Capital (ROIC) -0.85
Return on Assets (ROA) -0.55
Return on Equity (ROE) -0.66

Liquidity (mrq)
Quick Ratio 4.53
Current Ratio 4.53

Balance Sheet (mrq) ($M)
Current Assets 199.36
Assets 217.59
Liabilities 62.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-03 13D/A Bain Capital Life Sciences Fund II, L.P. 4.50 0.00
09-16 13G Bb Biotech Ag 5.80 0.00
02-12 13G Avoro Capital Advisors LLC 9.90
02-12 13G/A Pfizer Inc 0.00 -100.00
02-11 13G/A Biotechnology Value Fund L P 0.00 -100.00
02-04 13G Wellington Management Group Llp 6.79 381.23
01-27 13G/A BlackRock Inc. 11.70 11.91
01-25 13G Sarissa Capital Management LP 5.50 0.53

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-05-10 10-Q Quarterly Report – 10-Q
2021-02-26 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-01-18 90,443 595,042 15.20
2022-01-13 89,979 505,310 17.81

(click for more detail)

(click for list of largest short owners)

Similar Companies
MRKR – Marker Therapeutics Inc MRNA – Moderna Inc
MRNS – Marinus Pharmaceuticals Inc MRTX – Mirati Therapeutics Inc
MRUS – Merus N.V.


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts